Intranasal Dexmedetomidine for Deep-sedated Pediatric Dental Patients
Status:
Not yet recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
It is important to choose an appropriate analgesia/sedation technique in pediatric dental
treatment. Premedication combined with intravenous anesthesia is often used in deep sedation
technique for pediatric dental treatment and it's a routine in most hospitals. Deep sedation
has its unique advantages such as avoiding the airway damage with an enhanced recovery.
Dexmedetomidine is suitable for intranasal mucosal administration as a premedication drug. It
has been proved with several beneficial characteristics in other clinical procedures.
This study intends to further explore the characteristics of nasal dexmedetomidine as
premedication in pediatric oral treatment under deep sedation.